Outcometrix

Outcometrix is a private healthcare consulting company focused on clinical outcome assessments and patient-reported outcomes for pharmaceutical development. The firm provides scientific, psychometric, regulatory, and methodological support related to the design, implementation, analysis, interpretation, and reporting of COA/PRO endpoints across drug development programs. Public references associate Outcometrix with senior-level consultants Cheryl Coon, PhD, and Jason Lundy, PhD, who have presented on meaningful change, mixed-methods research, and paper-to-electronic PRO migration. Based on the available evidence, Outcometrix appears to operate as a specialized services business rather than a therapeutics developer, with no disclosed drug pipeline or proprietary clinical-stage assets. The company has been associated with U.S. locations in Arizona, Colorado, and Massachusetts through public business registrations and professional affiliations.